Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

LUIS CASAUBON

Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism

NPI
1447225495
CMS profile
20091
Location
AUSTIN, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$271.82

14 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $196.82 11
Education $75.00 3

By paying entity

PY2023 · entire year · sorted by reported total

Paying entityAmountRecords
Currax Pharmaceuticals LLC $75.00 3
Lilly USA, LLC $43.66 2
Abbott Laboratories $40.05 2
Medtronic, Inc. $38.70 2
Novo Nordisk Inc $36.09 2
Tandem Diabetes Care, Inc. $18.42 1
PFIZER INC. $13.67 1
BETA BIONICS, INC. $6.23 1

Page 1 of 1; records 1–14 of 14 matching records. This page contains 14 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

LUIS CASAUBON

NPI 1447225495 · CMS profile ID 20091

Allopathic & Osteopathic Physicians / Internal Medicine / Endocrinology, Diabetes & Metabolism

AUSTIN, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–14 of 14 matching records. This page contains 14 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1447225495?year=2023&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
LUIS CASAUBON, NPI 1447225495, CMS profile ID 20091. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–14 of 14 matching records. This page contains 14 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1447225495?year=2023&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). LUIS CASAUBON, NPI 1447225495, CMS profile ID 20091. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–14 of 14 matching records. This page contains 14 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1447225495?year=2023&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
LUIS CASAUBON, NPI 1447225495, CMS profile ID 20091, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–14 of 14 matching records. This page contains 14 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1447225495?year=2023&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

14 matching records · $271.82 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 14 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–14 of 14.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Lilly USA, LLC $26.0311/30/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1031857557 CMS
Currax Pharmaceuticals LLC $25.0011/15/2023 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 986427785 CMS
Currax Pharmaceuticals LLC $25.0011/15/2023 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 986427789 CMS
Tandem Diabetes Care, Inc. $18.4210/30/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1060265119 CMS
BETA BIONICS, INC. $6.2310/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1060384155 CMS
Currax Pharmaceuticals LLC $25.0010/18/2023 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 986427793 CMS
Novo Nordisk Inc $18.6910/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1002105111 CMS
Abbott Laboratories $15.1610/04/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1019588165 CMS
Medtronic, Inc. $21.6909/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025639765 CMS
Lilly USA, LLC $17.6308/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1031907383 CMS
Medtronic, Inc. $17.0107/04/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025639749 CMS
Novo Nordisk Inc $17.4004/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1002105099 CMS
Abbott Laboratories $24.8903/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1018893209 CMS
PFIZER INC. $13.6702/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049598893 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $17.84 1
PY2021 $120.24 6
PY2022 $75.60 4
PY2023 $271.82 14
PY2024 $436.66 18
PY2025 $588.22 24

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Source files
Dataset page · Bulk file · PY2019 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $244,802.34 43
PY2024 Principal investigator $270,911.58 97
PY2023 Principal investigator $213,259.54 161
PY2022 Principal investigator $530,223.08 203
PY2021 Principal investigator $866,406.89 1,203
PY2020 Recipient $7,732.50 3
PY2020 Principal investigator $630,563.16 449
PY2019 Principal investigator $775,897.49 183

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

97 records in PY2024

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Medtronic, Inc. $1,029.06 12/31/2024 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP341 IMPACT2 No dispute reported 06/30/2026 1103125541
Principal investigator 1 Novo Nordisk AS $832.50 12/20/2024 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 1096806744
Principal investigator 1 Novo Nordisk AS $1,027.80 12/20/2024 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 1096811804
Principal investigator 1 Medtronic, Inc. $284.00 12/17/2024 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP337 SUCCEED No dispute reported 06/30/2026 1103115583
Principal investigator 1 Medtronic, Inc. $237.00 12/12/2024 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP341 IMPACT2 No dispute reported 06/30/2026 1103118043
Principal investigator 1 Medtronic, Inc. $1,410.00 12/02/2024 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP341 IMPACT2 No dispute reported 06/30/2026 1103118041
Principal investigator 1 Novo Nordisk AS $3,162.50 12/02/2024 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 1096739408
Principal investigator 1 Abbott Laboratories $33,440.34 11/25/2024 Non-covered Recipient Entity
Texas Diabetes & Endocrinology (TDE)
Ketone Diet Study No dispute reported 06/30/2026 1146169074
Principal investigator 1 Novo Nordisk AS $1,259.18 11/20/2024 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 1096760570
Principal investigator 1 AstraZeneca Pharmaceuticals LP $17,419.30 11/13/2024 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
A Phase II Randomised Double blind Placebo controlled Study to Evaluate the Efficacy Safety and Tolerability of AZD6234 in Participants Living with Obesity or Overweight with Comorbidity No dispute reported 06/30/2026 1110837200
Principal investigator 1 Abbott Laboratories $165.86 11/08/2024 Non-covered Recipient Entity
Texas Diabetes & Endocrinology (TDE)
Ketone Diet Study No dispute reported 06/30/2026 1146169082
Principal investigator 1 Medtronic, Inc. $1,891.00 11/07/2024 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP341 IMPACT2 No dispute reported 06/30/2026 1103118039
Principal investigator 1 Abbott Laboratories $554.23 11/04/2024 Non-covered Recipient Entity
Texas Diabetes & Endocrinology (TDE)
Ketone Diet Study No dispute reported 06/30/2026 1146169084
Principal investigator 1 Abbott Laboratories $29,957.99 11/04/2024 Non-covered Recipient Entity
Texas Diabetes & Endocrinology (TDE)
Ketone Diet Study No dispute reported 06/30/2026 1146169086
Principal investigator 1 Novo Nordisk AS $23.06 10/25/2024 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 1096750090
Principal investigator 1 Abbott Laboratories $32,719.48 10/08/2024 Non-covered Recipient Entity
Texas Diabetes & Endocrinology (TDE)
Ketone Diet Study No dispute reported 06/30/2026 1146169072
Principal investigator 1 Abbott Laboratories $584.82 10/04/2024 Non-covered Recipient Entity
Texas Diabetes & Endocrinology (TDE)
Ketone Diet Study No dispute reported 06/30/2026 1146169080
Principal investigator 1 Abbott Laboratories $783.16 09/30/2024 Non-covered Recipient Entity
Texas Diabetes & Endocrinology (TDE)
Ketone Diet Study No dispute reported 06/30/2026 1146169076
Principal investigator 1 Abbott Laboratories $69.60 09/24/2024 Non-covered Recipient Entity
Texas Diabetes & Endocrinology (TDE)
Ketone Diet Study No dispute reported 06/30/2026 1146169138
Principal investigator 1 Novo Nordisk AS $150.00 09/20/2024 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 1096736980
Principal investigator 1 Novo Nordisk AS $1,694.26 09/20/2024 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 1096831451
Principal investigator 1 Abbott Laboratories $19,380.00 09/17/2024 Non-covered Recipient Entity
Texas Diabetes & Endocrinology (TDE)
Ketone Diet Study No dispute reported 06/30/2026 1146169070
Principal investigator 1 Medtronic, Inc. $2,100.00 09/13/2024 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP341 IMPACT2 No dispute reported 06/30/2026 1103118037
Principal investigator 1 Medtronic, Inc. $42.00 09/11/2024 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP331 Smart Pen No dispute reported 06/30/2026 1103113427
Principal investigator 1 Medtronic, Inc. $1,716.00 08/23/2024 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP341 IMPACT2 No dispute reported 06/30/2026 1103118035
Principal investigator 1 Novo Nordisk AS $2,464.28 08/23/2024 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 1096885197
Principal investigator 1 Novo Nordisk AS $2,948.40 08/21/2024 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 1096743959
Principal investigator 1 Novo Nordisk AS $500.00 08/21/2024 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 1096775588
Principal investigator 1 Novo Nordisk AS $3,555.57 08/21/2024 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 1096809070
Principal investigator 1 Abbott Laboratories $1,111.04 08/20/2024 Non-covered Recipient Entity
Texas Diabetes & Endocrinology (TDE)
Ketone Diet Study No dispute reported 06/30/2026 1146169078
Principal investigator 1 Abbott Laboratories $4,000.00 08/05/2024 Non-covered Recipient Entity
Texas Diabetes & Endocrinology (TDE)
Ketone Diet Study No dispute reported 06/30/2026 1146169068
Principal investigator 1 Novo Nordisk AS $982.80 07/22/2024 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 1096767590
Principal investigator 1 Novo Nordisk AS $843.75 07/22/2024 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 1096773543
Principal investigator 1 Novo Nordisk AS $9,559.74 07/22/2024 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 1096833688
Principal investigator 1 Medtronic, Inc. $3,668.00 07/17/2024 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP341 IMPACT2 No dispute reported 06/30/2026 1103118033
Principal investigator 1 Abbott Laboratories $5.00 07/08/2024 Non-covered Recipient Entity
Texas Diabetes & Endocrinology (TDE)
Ketone Diet Study No dispute reported 06/30/2026 1146169114
Principal investigator 1 Abbott Laboratories $21.00 07/08/2024 Non-covered Recipient Entity
Texas Diabetes & Endocrinology (TDE)
Ketone Diet Study No dispute reported 06/30/2026 1146169116
Principal investigator 1 Abbott Laboratories $7.20 07/08/2024 Non-covered Recipient Entity
Texas Diabetes & Endocrinology (TDE)
Ketone Diet Study No dispute reported 06/30/2026 1146169118
Principal investigator 1 Abbott Laboratories $5.60 07/08/2024 Non-covered Recipient Entity
Texas Diabetes & Endocrinology (TDE)
Ketone Diet Study No dispute reported 06/30/2026 1146169120
Principal investigator 1 Abbott Laboratories $25.20 07/08/2024 Non-covered Recipient Entity
Texas Diabetes & Endocrinology (TDE)
Ketone Diet Study No dispute reported 06/30/2026 1146169122
Principal investigator 1 Abbott Laboratories $114.20 07/08/2024 Non-covered Recipient Entity
Texas Diabetes & Endocrinology (TDE)
Ketone Diet Study No dispute reported 06/30/2026 1146169124
Principal investigator 1 Abbott Laboratories $8.85 07/08/2024 Non-covered Recipient Entity
Texas Diabetes & Endocrinology (TDE)
Ketone Diet Study No dispute reported 06/30/2026 1146169126
Principal investigator 1 Abbott Laboratories $192.50 07/08/2024 Non-covered Recipient Entity
Texas Diabetes & Endocrinology (TDE)
Ketone Diet Study No dispute reported 06/30/2026 1146169128
Principal investigator 1 Abbott Laboratories $10,773.00 07/08/2024 Non-covered Recipient Entity
Texas Diabetes & Endocrinology (TDE)
Ketone Diet Study No dispute reported 06/30/2026 1146169130
Principal investigator 1 Abbott Laboratories $444.00 07/08/2024 Non-covered Recipient Entity
Texas Diabetes & Endocrinology (TDE)
Ketone Diet Study No dispute reported 06/30/2026 1146169132
Principal investigator 1 Abbott Laboratories $174.00 07/08/2024 Non-covered Recipient Entity
Texas Diabetes & Endocrinology (TDE)
Ketone Diet Study No dispute reported 06/30/2026 1146169134
Principal investigator 1 Abbott Laboratories $37.98 07/08/2024 Non-covered Recipient Entity
Texas Diabetes & Endocrinology (TDE)
Ketone Diet Study No dispute reported 06/30/2026 1146169136
Principal investigator 1 Medtronic, Inc. $9,498.56 06/30/2024 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP341 IMPACT2 No dispute reported 06/30/2026 1103124691
Principal investigator 1 Novo Nordisk AS $1,576.80 06/21/2024 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 1096753920
Principal investigator 1 Novo Nordisk AS $1,614.37 06/21/2024 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 1096829151
Principal investigator 1 Novo Nordisk AS $1,117.41 06/21/2024 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 1096866156
Principal investigator 1 Novo Nordisk AS $23.06 06/20/2024 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 1096795495
Principal investigator 1 Medtronic, Inc. $3,921.00 06/18/2024 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP341 IMPACT2 No dispute reported 06/30/2026 1103118031
Principal investigator 1 Medtronic, Inc. $1,060.00 06/10/2024 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP341 IMPACT2 No dispute reported 06/30/2026 1103118029
Principal investigator 1 Novo Nordisk AS $23.06 06/05/2024 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 1096834409
Principal investigator 1 Novo Nordisk AS $150.00 05/31/2024 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 1096726735
Principal investigator 1 Novo Nordisk AS $1,063.12 05/31/2024 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 1096785536
Principal investigator 1 Novo Nordisk AS $1,535.35 05/29/2024 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 1096871860
Principal investigator 1 Medtronic, Inc. $8,561.00 05/21/2024 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP341 IMPACT2 No dispute reported 06/30/2026 1103118027
Principal investigator 1 Novo Nordisk AS $23.06 05/20/2024 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 1096807344
Principal investigator 1 Medtronic, Inc. $1,650.00 05/09/2024 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP331 Smart Pen No dispute reported 06/30/2026 1103113425
Principal investigator 1 Novo Nordisk AS $23.06 05/08/2024 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 1096737282
Principal investigator 1 Novo Nordisk AS $23.06 05/02/2024 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 1096816748
Principal investigator 1 Novo Nordisk AS $1,417.50 04/30/2024 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 1096808937
Principal investigator 1 Novo Nordisk AS $1,117.41 04/30/2024 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 1096811461
Principal investigator 1 Medtronic, Inc. $5,812.50 04/26/2024 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP321 AHCL Pivotal Study No dispute reported 06/30/2026 1103108069
Principal investigator 1 Novo Nordisk AS $23.06 04/26/2024 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 1096769026
Principal investigator 1 Medtronic, Inc. $4,326.00 04/24/2024 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP341 IMPACT2 No dispute reported 06/30/2026 1103118025
Principal investigator 1 Medtronic, Inc. $2,645.00 04/09/2024 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP341 IMPACT2 No dispute reported 06/30/2026 1103118023
Principal investigator 1 Novo Nordisk AS $23.06 04/05/2024 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 1096854082
Principal investigator 1 Novo Nordisk AS $191.88 04/02/2024 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 1096760802
Principal investigator 1 Novo Nordisk AS $43.62 04/02/2024 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 1096812483
Principal investigator 1 Novo Nordisk AS $1,152.60 03/29/2024 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 1096835082
Principal investigator 1 Novo Nordisk AS $1,988.44 03/27/2024 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 1096774772
Principal investigator 1 Novo Nordisk AS $23.06 03/27/2024 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 1096861717
Principal investigator 1 Medtronic, Inc. $1,650.00 03/22/2024 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP321 AHCL Pivotal Study No dispute reported 06/30/2026 1103108067
Principal investigator 1 Medtronic, Inc. $3,515.00 03/21/2024 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP341 IMPACT2 No dispute reported 06/30/2026 1103118021
Principal investigator 1 Novo Nordisk AS $23.06 03/21/2024 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 1096868781
Principal investigator 1 Medtronic, Inc. $1,650.00 03/07/2024 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP337 SUCCEED No dispute reported 06/30/2026 1103115581
Principal investigator 1 Novo Nordisk AS $23.06 03/06/2024 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 1096805912
Principal investigator 1 Novo Nordisk AS $1,535.35 02/29/2024 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 1096784825
Principal investigator 1 Medtronic, Inc. $81.00 02/23/2024 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP337 SUCCEED No dispute reported 06/30/2026 1103115579
Principal investigator 1 Novo Nordisk AS $1,188.00 02/23/2024 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 1096743070
Principal investigator 1 Novo Nordisk AS $1,895.62 02/23/2024 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 1096831580
Principal investigator 1 Novo Nordisk AS $23.06 02/19/2024 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 1096719674
Principal investigator 1 Medtronic, Inc. $3,319.00 02/12/2024 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP341 IMPACT2 No dispute reported 06/30/2026 1103118019
Principal investigator 1 Novo Nordisk AS $23.06 02/07/2024 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 1096732879
Principal investigator 1 Medtronic, Inc. $212.00 02/06/2024 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP337 SUCCEED No dispute reported 06/30/2026 1103115577
Principal investigator 1 Novo Nordisk AS $23.06 02/01/2024 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 1096883188
Principal investigator 1 Novo Nordisk AS $1,782.00 01/29/2024 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 1096732251
Principal investigator 1 Novo Nordisk AS $2,311.87 01/29/2024 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 1096774045
Principal investigator 1 Novo Nordisk AS $300.00 01/29/2024 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 1096826995
Principal investigator 1 Medtronic, Inc. $43.18 01/24/2024 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP321 AHCL Pivotal Study No dispute reported 06/30/2026 1103108065
Principal investigator 1 Novo Nordisk AS $2,124.85 01/24/2024 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 1096828092
Principal investigator 1 Medtronic, Inc. $5,140.00 01/15/2024 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP341 IMPACT2 No dispute reported 06/30/2026 1103118045
Principal investigator 1 Novo Nordisk AS $23.06 01/05/2024 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 1096744206
Principal investigator 1 Novo Nordisk AS $23.06 01/02/2024 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 1096880919